PT  - JOURNAL ARTICLE
AU  - Spiller, Wes
AU  - Hartwig, Fernando Pires
AU  - Sanderson, Eleanor
AU  - Smith, George Davey
AU  - Bowden, Jack
TI  - Interaction-based Mendelian randomization with measured and unmeasured gene-by-covariate interactions
AID  - 10.1101/2020.07.27.20162909
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.07.27.20162909
4099  - http://medrxiv.org/content/early/2020/07/29/2020.07.27.20162909.short
4100  - http://medrxiv.org/content/early/2020/07/29/2020.07.27.20162909.full
AB  - Studies leveraging gene-environment (GxE) interactions within Mendelian randomization (MR) analyses have prompted the emergence of two methodologies: MR-GxE and MR-GENIUS. Such methods are attractive in allowing for pleiotropic bias to be corrected when using individual instruments. Specifically, MR-GxE requires an interaction to be explicitly identified, while MR-GENIUS does not. We critically examine the assumptions of MR-GxE and MR-GENIUS, and propose sensitivity analyses to evaluate their performance. Finally, we explore the association between body mass index (BMI) and systolic blood pressure (SBP) using data from the UK Biobank. We find both approaches share similar assumptions, though differences between the approaches lend themselves to differing research settings. Where interactions are identified, MR-GxE relies on weaker assumptions and allows for further sensitivity analyses. MR-GENIUS circumvents the need to identify interactions, but relies on the MR-GxE assumptions holding globally. Through applied analyses we find evidence of a positive effect of BMI upon SBP.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWes Spiller is supported by a Wellcome Trust studentship (108902/B/15/Z).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Study was performed using data from the UK Biobank, and ethical use of the data is monitored by The University of Bristol.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesUK Biobank data was used, accessed through application number 8786. For more information, please visit https://www.ukbiobank.ac.uk/